Gutkind Lab

Translating our scientific discoveries into novel precision treatment options and immunotherapies to prevent and treat cancer.

Research

G proteins/GPCRs and Cancer


GPCRs, the largest family of cell-surface molecules involved in signal transmission, have recently emerged as crucial players in tumour growth and metastasis.
more

HNSCC / Oral Cancer / PI3K-mTOR


The PI3K/mTOR signaling pathway is one of the most frequently dysregulated molecular mechanisms in HNSCC. mTOR inhibition halts tumor progression.
more

Immune Oncology


Recent revolutionary therapeutic strategies restoring T cell mediated anti-tumor immunity by immune modulating agents have achieved remarkable clinical responses including in HNSCC.
more

Uveal Melanoma


Around 90% of ocular melanomas harbor gain-of- function mutations in GNAQ or GNA11, where they are now consideretd to represent the driver oncogenes.
more
 

News

October 6, 2020

UC San Diego Health Sciences News

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at University of California San Diego School of Medicine.

Gutkind joined the UC San Diego School of Medicine faculty in 2015 and has served as Distinguished Professor in the Department of Pharmacology, as well as associate director of basic science and co-director of the Head and Neck Cancer Center at Moores Cancer Center.

Read more


October 19, 2019

UC San Diego Health Sciences News

UC San Diego Moores Cancer Center's J. Silvio Gutkind Joins National Academy of Medicine

Considered one of the highest honors in the fields of health and medicine, J. Silvio Gutkind, PhD, Distinguished Professor of Pharmacology at University of California San Diego School of Medicine and associate director for basic science at Moores Cancer Center, has been elected to the National Academy of Medicine (NAM).

Read more


January 13, 2020

UC San Diego Health Sciences News

How Marijuana Accelerates Growth of HPV-related Head and Neck Cancer Identified

University of California San Diego School of Medicine researchers have identified the molecular mechanism activated by the presence of tetrahydrocannabinol (THC) - the ingredient that causes people to feel the euphoria or 'high' associated with cannabis - in the bloodstream that accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.

Read more